Market OverviewThe projected growth of the Global Dyspnea Treatment Market from USD 6.3 billion in 2023 to USD 12.2 billion by 2033, at a compound annual growth rate (CAGR) of 6.8%, reflects increasing demand for treatments addressing dyspnea a common symptom associated with various respiratory diseases, heart condi.